Tenet Healthcare Corporation $THC Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. trimmed its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 0.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 616,699 shares of the company’s stock after selling 2,165 shares during the period. Victory Capital Management Inc. owned about 0.70% of Tenet Healthcare worth $125,215,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the business. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare in the third quarter valued at about $32,000. Westside Investment Management Inc. boosted its holdings in Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after purchasing an additional 96 shares during the last quarter. Trust Co. of Vermont purchased a new stake in Tenet Healthcare during the 3rd quarter worth approximately $41,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at approximately $35,000. Finally, True Wealth Design LLC boosted its stake in shares of Tenet Healthcare by 238.2% during the 2nd quarter. True Wealth Design LLC now owns 257 shares of the company’s stock valued at $45,000 after buying an additional 181 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Royal Bank Of Canada increased their price objective on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research note on Thursday, February 12th. Jefferies Financial Group increased their target price on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Truist Financial increased their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $247.67.

Insider Activity

In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Thomas W. Arnst sold 24,000 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the sale, the executive vice president directly owned 8,012 shares of the company’s stock, valued at approximately $1,875,128.48. This represents a 74.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 34,195 shares of company stock worth $7,912,606. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $244.10 on Thursday. The stock’s 50 day moving average price is $208.54 and its 200 day moving average price is $201.39. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The stock has a market cap of $21.23 billion, a price-to-earnings ratio of 15.76, a PEG ratio of 1.20 and a beta of 1.39. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $245.98.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same quarter in the previous year, the business earned $3.44 EPS. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.